Text Size

National Survey on Hypertension in General Practitioner (GP) Consultation (Prophyl GP)

This study has been completed.
Sponsor:
Information provided by:
AstraZeneca
ClinicalTrials.gov Identifier:
NCT00695656
First received: June 10, 2008
Last updated: August 4, 2009
Last verified: August 2009
History of Changes
  Purpose

To evaluate (with sufficient accuracy) the profile(demographic and clinical characteristics, health care management) of hypertensive patients seen in general practitioner consultation.


Condition
Hypertension

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Profile of Hypertensive Patients Seen in General Practitioner Consultation

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by AstraZeneca:

Primary Outcome Measures:
  • Demographic, clinical and health care characteristics [ Time Frame: Once ]

Enrollment: 2853
Study Start Date: April 2008
Study Completion Date: November 2008

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

First three consecutive patients with hypertension seen by general practitioner

Criteria

Inclusion Criteria:

  • male or female > or = 18 years old
  • Known hypertension
  • agree to take part in this study

Exclusion Criteria:

  • none
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00695656

  Show 1387 Study Locations
Sponsors and Collaborators
AstraZeneca
Investigators
Study Director: Castaigne, Medical Director AstraZeneca
  More Information

No publications provided

Responsible Party: Alain Castaigne, Medical Director, AstraZeneca Pharmaceuticals
ClinicalTrials.gov Identifier: NCT00695656     History of Changes
Other Study ID Numbers: NIS-CFR-DUM-2007/7
Study First Received: June 10, 2008
Last Updated: August 4, 2009
Health Authority: France: French Data Protection Authority

Keywords provided by AstraZeneca:
Hypertension
general practitioner consultation
Patients with hypertension

Additional relevant MeSH terms:
Hypertension
Vascular Diseases
Cardiovascular Diseases

ClinicalTrials.gov processed this record on May 16, 2013